Using advanced gene editing to create precise cancer models in mice

In vivo prime editing for precision cancer mouse models

NIH-funded research Univ of Massachusetts Med Sch Worcester · NIH-10909321

This study is exploring a new way to edit genes in mice to better understand cancer by creating models that mimic real cancer mutations, which could help researchers find better treatments and tests for patients.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniv of Massachusetts Med Sch Worcester NIH-funded
Lab location1 site (Worcester, United States)
Project IDNIH-10909321 on NIH RePORTER

What this research studies

This research focuses on developing a new gene editing technique called prime editing to create accurate mouse models of cancer. By using this method, researchers aim to replicate various cancer mutations directly in adult mouse tissues, which can help in understanding how these mutations contribute to tumor growth and treatment resistance. The approach allows for rapid and flexible modeling of cancer, potentially leading to better interventions and biomarkers for patients. The study seeks to optimize this technique to improve the efficiency of generating these models.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals with specific cancer mutations that are being studied in the mouse models.

Not a fit: Patients without identifiable cancer mutations or those not involved in the specific types of cancer being modeled may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to more effective cancer treatments and personalized medicine approaches for patients.

How similar studies have performed: Other research has shown promise with CRISPR-based approaches, but prime editing is a newer and less tested method in this context.

Where this research is happening

Worcester, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-09 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.